Applied Therapeutics executive sells $17,151 in stock
Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer of Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company with a market capitalization of ...
American Association of Individual Investors1d
Which Is a Better Investment, Biogen Inc. or Neurocrine Biosciences, Inc. Stock?
Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Liquidia Corp.: We Have Exposure To The Upside Now
If PH-ILD studies translate into the real world, the market opportunity for Liquidia is enormous. Where should we expect LQDA stock to be in the next few months? Find out.
Dyne Therapeutics, Inc. (DYN): Among the Best Rebound Stocks to Invest In Now
We recently compiled a list of the 10 Best Rebound Stocks To Invest In Now. In this article, we are going to take a look at ...
3 Penny Stocks On US Exchanges With Market Caps Under $500M
U.S. stock markets are riding high, with major indexes nearing record levels following a rally led by chipmakers like Nvidia. In this context, penny stocks—typically smaller or newer companies—remain ...
American Association of Individual Investors2d
Which Is a Better Investment, Biogen Inc. or Gilead Sciences, Inc. Stock?
Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Arquitos Capital Management Q4 2024 Commentary
Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...
PTC Therapeutics (NASDAQ:PTCT) Shares Up 6.1% Following Analyst Upgrade
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% during trading on Monday after Cantor Fitzgerald raised their price target on the stock from $76.00 to $113.00. Cantor ...
Arcturus Therapeutics' SWOT analysis: mRNA innovator's stock faces pivotal year
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...
United Therapeutics announces FDA clearance of UKidney NDA
United Therapeutics (UTHR) announced that the FDA has cleared its investigational new drug application to initiate a clinical study of the ...
TG Therapeutics (NASDAQ:TGTX) Stock Rating Lowered by StockNews.com
StockNews.com lowered shares of TG Therapeutics (NASDAQ:TGTX – Free Report) from a hold rating to a sell rating in a report published on Friday. Several other research analysts have also recently ...
Why Akero Therapeutics (AKRO) Is Among the Best Booming Stocks to Invest in Now?
We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...